Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Gesierich

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2016
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodesChristina Bluemel, Gonca Safak, Andreas Cramer, et al.
Melanoma Research|May 22, 2018
Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitorsAlexander Thiem, Patrick Schummer, Simon Ueberschaar, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 5, 2023
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center studyAgmal Scherzad, Manuel Stöth, Till J Meyer, et al.
The British Journal of Dermatology|September 4, 2025
Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II studySebastian Haferkamp, Bastian Schilling, Carola Berking, et al.
Acta Dermato-Venereologica|January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective StudySimon Goller, Tassilo Dege, Patrick Schummer, et al.
Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.
Journal of the American Academy of Dermatology|February 1, 2019
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, et al.
Clinical Biochemistry|April 28, 2022
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoringFatemeh Aghai-Trommeschlaeger, Sebastian Zimmermann, Anja Gesierich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
BMC Cancer|August 12, 2017
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine careMarkus V Heppt, Timo Siepmann, Jutta Engel, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2016
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodesChristina Bluemel, Gonca Safak, Andreas Cramer, et al.
Melanoma Research|May 22, 2018
Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitorsAlexander Thiem, Patrick Schummer, Simon Ueberschaar, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 5, 2023
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center studyAgmal Scherzad, Manuel Stöth, Till J Meyer, et al.
The British Journal of Dermatology|September 4, 2025
Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II studySebastian Haferkamp, Bastian Schilling, Carola Berking, et al.
Acta Dermato-Venereologica|January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective StudySimon Goller, Tassilo Dege, Patrick Schummer, et al.
Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.
Journal of the American Academy of Dermatology|February 1, 2019
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, et al.
Clinical Biochemistry|April 28, 2022
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoringFatemeh Aghai-Trommeschlaeger, Sebastian Zimmermann, Anja Gesierich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
BMC Cancer|August 12, 2017
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine careMarkus V Heppt, Timo Siepmann, Jutta Engel, et al.
Pageof 10